Report Detail
North America Immunochemistry Market to 2027 - Regional Analysis and Forecasts By Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others), and Country
- RnM3876517 |
- 07 February, 2020 |
- Global |
- 194 Pages |
- The Insight Partners |
- Biotechnology
The North America immunochemistry market is expected to reach US$ 1,536.87 Mn in 2027 from US$ 806.34 Mn in 2018. The market is anticipated to grow with a CAGR of 7.6 % from 2019-2027.
The growth of the immunochemistry market is primarily attributed to the rising incidences of chronic and infectious diseases and the increasing geriatric population. However, the limitations associated with immunohistochemistry is likely to have a negative impact on market growth. On the other hand, development opportunities in the region are likely to have a positive impact on the growth of the North America immunochemistry market in the coming years.
The growing elderly population is the primary cause of chronic diseases. Aging is a complex process influenced by genetic variables as well as environmental factors. Thus, people with the age of 75 years and above high blood pressure are the common risk factor for cardiovascular diseases, including blood-associated cancer. Management of these disorders in older patients must often be weighed in a setting of decreased physiological reserves and concurrent illnesses. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people across the world who were aged 60 years or over, and the number is expected to reach nearly 2.1 billion by 2050. Also, as per the analysis of the US Census Bureau the number of Americans above the age of 65 and older is anticipated to grow more than double from 46 million in 2016 to above 98 million by 2060, and the 65-and-older age group’s share in the world’s population will produce around 24% from 15 percent.
According to the National Council on Aging, approximately 80% of adults suffer from at least one chronic disease, whereas 77% of aged people suffer from two. These chronic diseases majorly comprise cancer, heart disease, diabetes, and stroke. Immunohistochemistry techniques help in the quantification and diagnosis of these diseases accurately and reliably. The rising geriatric population in the world is thus likely to grow the immunohistochemistry market in the forecast period.
In 2018, the diagnostics segment accounted for the largest market share in the North America immunohistochemistry market by the application. The growing benefits of immunohistochemistry have prolonged technology usage to diagnose several chronic diseases. The application of the molecular diagnostics has allowed to treat the patients as per their genetic make-up also diagnosis through immunohistochemistry that helps to increase the use in precision medicine. Even the cost-effective nature of the immunochemistry is driving significant growth across the region.
In 2018, the antibodies held the largest market share of the immunochemistry market by the product that also anticipated to dominate the market in 2027. Moreover, the reagent segment is anticipated to register the highest CAGR during the forecast period in the market, since they form an essential component of any reaction and can be chosen as per the result to be obtained.
In 2018, the hospital & diagnostic laboratories segment held the most significant market share of the immunochemistry market, by the end-user. This segment is also anticipated to dominate the market in 2027. Besides, the segment is also expected to grow at the fastest rate during the coming years due to the rise in the prevalence of infectious diseases, cancer, and autoimmune disorders.
Some of the major primary and secondary sources for immunochemistry included in the report are, Federation of AIDS Organisations (AFAO), American Heart Association (AHA), HIV and AIDS organization (AVERT), Centers for Disease Control and Prevention (CDC), Centers for Diabetes and Endocrinology (CDE), Food and Drug Administration (FDA) and others.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
2. North America Immunochemistry Market– Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Immunochemistry Market – Market Landscape
- 4.1 Overview
- 4.2 Market Segmentation
- 4.2.1 North America Immunochemistry Market – By Product
- 4.2.2 North America Immunochemistry Market – By Application
- 4.2.3 North America Immunochemistry Market – By End User
- 4.2.4 North America Immunochemistry Market – By Country
- 4.3 PEST Analysis
5. North America Immunochemistry Market - Key Market Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Rising Incidences of Chronic and Infectious Diseases
- 5.1.2 Increasing Geriatric Population
- 5.2 Key Market Restraints
- 5.2.1 Limitations Associated with Immunohistochemistry
- 5.3 Key Market Opportunities
- 5.3.1 Development Opportunities in Emerging Countries
- 5.4 Future Trends
- 5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
- 5.5 Impact Analysis
6. Immunochemistry Market – North America Analysis
- 6.1 North America Immunochemistry Market Revenue Forecasts And Analysis
- 6.2 Performance of Key Players
7. North America Immunochemistry Market Analysis – By Application
- 7.1 Overview
- 7.2 North America Immunochemistry Market, By Application, 2018 & 2027 (%)
- 7.3 North America Immunochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 7.4 Diagnostics
- 7.4.1 Overview
- 7.4.2 North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.3 Cancer
- 7.4.3.1 Overview
- 7.4.3.2 North America Cancer Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4 Infectious Diseases
- 7.4.4.1 Overview
- 7.4.4.2 North America Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.5 Autoimmune Diseases
- 7.4.5.1 Overview
- 7.4.5.2 North America Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.6 Nephrological Diseases
- 7.4.6.1 Overview
- 7.4.6.2 North America Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5 Drug Testing
- 7.5.1 Overview
- 7.5.2 North America Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Immunochemistry Market Analysis – By Product
- 8.1 Overview
- 8.2 North America Immunochemistry Market, By Product, 2018 & 2027 (%)
- 8.3 North America Immunochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 8.3.1 North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.2 North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.2.1 North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4 Antibodies Market
- 8.4.1 Overview
- 8.4.2 North America Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.3 Primary Antibodies
- 8.4.3.1 Overview
- 8.4.3.2 North America Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.4 Secondary Antibodies
- 8.4.4.1 Overview
- 8.4.4.2 North America Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5 Equipment
- 8.5.1 Overview
- 8.5.2 North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.3 Slide Staining Systems
- 8.5.3.1 Overview
- 8.5.3.2 North America Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.4 Tissue Microarrays
- 8.5.4.1 Overview
- 8.5.4.2 North America Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.5 Slide Scanners
- 8.5.5.1 Overview
- 8.5.5.2 North America Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.6 Other Equipment
- 8.5.6.1 Overview
- 8.5.6.2 North America Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6 Reagents
- 8.6.1 Overview
- 8.6.2 North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.3 Histological Stains
- 8.6.3.1 Overview
- 8.6.3.2 North America Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.4 Blocking & Fixation Reagents
- 8.6.4.1 Overview
- 8.6.4.2 North America Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.5 Chromogenic Substrates
- 8.6.5.1 Overview
- 8.6.5.2 North America Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.6 Stabilizers
- 8.6.6.1 Overview
- 8.6.6.2 North America Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.7 Proteolytic Enzymes
- 8.6.7.1 Overview
- 8.6.7.2 North America Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.6.8 Solvents
- 8.6.8.1 Overview
- 8.6.8.2 North America Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.7 Kits
- 8.7.1 Overview
- 8.7.2 North America Kits Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Immunochemistry Market Analysis – By End User
- 9.1 Overview
- 9.2 North America Immunochemistry Market, By End User, 2018 & 2027 (%)
- 9.3 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 9.4 Hospital & Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 North America Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5 Research Institutes
- 9.5.1 Overview
- 9.5.2 North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.6 Others End Users
- 9.6.1 Overview
- 9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America Immunochemistry Market Revenue and Forecasts To 2027
- 10.1 Overview
- 10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.2 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 10.1.2.1 North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 10.1.3 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.3.1 North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 10.1.3.2 North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 10.1.3.3 North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 10.1.4 North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.5 North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
- 10.1.6 US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.6.1 US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.6.2 US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 10.1.6.2.1 US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.6.3 US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.6.3.1 US Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.6.3.2 US Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.6.3.3 US Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.6.4 US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.7 Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.2 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 10.1.7.2.1 Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.7.3 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.7.3.1 Canada Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.7.3.2 Canada Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.7.3.3 Canada Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.7.4 Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.8 Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.2 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 10.1.8.2.1 Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.8.3 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.8.3.1 Mexico Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.8.3.2 Mexico Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.8.3.3 Mexico Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
- 10.1.8.4 Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Immunochemistry Market – Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies done by the companies in the Market, 2018 (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic developments
- 11.4.1 Overview
12. Immunohistochemistry Market–Key Company Profiles
- 12.1 Bio SB
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Financial Overview
- 12.1.4 Product portfolio
- 12.1.5 SWOT ANALYSIS
- 12.1.6 Key Developments
- 12.2 Cell Signaling Technology, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Financial Overview
- 12.2.4 Product portfolio
- 12.2.5 SWOT ANALYSIS
- 12.2.6 Key Developments
- 12.3 F. Hoffmann-La Roche Ltd.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Financial Overview
- 12.3.4 Product Portfolio
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Merck KGaA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Financial Overview
- 12.4.4 Product Portfolio
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 PerkinElmer, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Financial Overview
- 12.5.4 Product Portfolio
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Thermo Fisher Scientific, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Financial Overview
- 12.6.4 Product Portfolio
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Abcam Plc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Financial Overview
- 12.7.4 Product Portfolio
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Agilent Technologies, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Financial Overview
- 12.8.4 Product Portfolio
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Bio-Rad Laboratories, Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Information
- 12.9.4 Product Portfolio
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Danaher
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Financial Information
- 12.10.4 Product Portfolio
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary Of Terms
- 13.3 Methodology
- 13.3.1 Coverage
- 13.3.2 Secondary Research
Summary:
Get latest Market Research Reports on North America Immunochemistry . Industry analysis & Market Report on North America Immunochemistry is a syndicated market report, published as North America Immunochemistry Market to 2027 - Regional Analysis and Forecasts By Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others), and Country . It is complete Research Study and Industry Analysis of North America Immunochemistry market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
